Immune manipulation by BCG administered before or after cyclophosphamide for chemo-immunotherapy of L1210 leukaemia
- 31 October 1974
- journal article
- Published by Elsevier
- Vol. 10 (10) , 661-666
- https://doi.org/10.1016/0014-2964(74)90005-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMAThe Lancet, 1973
- Immunological Effects of BCG in Malignant Melanoma: Two Modes of Administration ComparedAnnals of Internal Medicine, 1972
- Factors determining cell killing by chemotherapeutic agents In Vivo—II.: Melphalan, chlorambucil and nitrogen mustardPublished by Elsevier ,1971
- Active ImmunotherapyAdvances in Cancer Research, 1971
- An experimental model of active immunotherapy preceded by cytoreductive chemotherapyPublished by Elsevier ,1970
- Factors determining cell killing by chemotherapeutic agents in vivo—I.Published by Elsevier ,1970
- Active Immunotherapy with Corynebacterium parvum and Chemotherapy in Murine FibrosarcomasBMJ, 1970
- Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.British Journal of Cancer, 1969
- ACTIVE IMMUNOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1969